secwatch / observer

8-K filed June 1, 2026, 12:41 PM ET ticker BUKS CIK 0000015847

other material confidence high sentiment neutral materiality 0.55

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP

CEO Christopher Reedy informed employees of new medical treatment following Mayo Clinic consultations; he has continued follow-ups since 2019 cancer diagnosis.
Reedy will continue as CEO and remain actively engaged with operations, leadership team, and Board.
Executive Chairman Jeffrey D. Yowell and Lead Independent Director Joseph P. Daly expressed full Board support for Reedy.
Treatment may periodically require time away from office; executive leadership team and Board will support ongoing operations.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000015847-26-000009
form_type: 8-K
ticker: BUKS
cik: 0000015847
company_name: BUTLER NATIONAL CORP
filed_at: 2026-06-01T16:41:32+00:00
discovered_at: 2026-06-01T16:42:00.281244+00:00
generated_at: 2026-06-01T16:42:13.838539+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000015847-26-000009
json_url: https://secwatch.observer/filing/0000015847-26-000009.json
markdown_url: https://secwatch.observer/filing/0000015847-26-000009.md
text_url: https://secwatch.observer/filing/0000015847-26-000009.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/0000015847-26-000009-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/buks-20260601.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

UFPI

UFP Industries authorizes $300M share repurchase program, replacing prior authorization

UFP INDUSTRIES INC June 1, 2026, 8:17 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

VRNO

Verano Announces 1-for-5 Reverse Stock Split, Reducing Shares to ~72.9M, to Facilitate U.S. Exchange Listing

Verano Holdings Corp. June 1, 2026, 7:15 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CATX

Perspective Therapeutics updates pipeline: VMT-α-NET durable disease control; VMT01 and PSV359 progress

Perspective Therapeutics, Inc. June 1, 2026, 6:30 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

RDAC

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0000015847-26-000009

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.